New-onset ulcerative colitis temporally associated with with ixekizumab in a psoriasis patient successfully treated with guselkunmab: A case report
Dermatologists closely monitor gastrointestinal symptoms in patients with psoriasis who are receiving ixekizumab to ensure safe medication use. Patients with ulcerative colitis and psoriasis may actively consider using guselkumab.
Authors
- Jing Tang (ORCID: https://orcid.org/0000-0002-6351-993X)
- Weijie Li (ORCID: https://orcid.org/0000-0001-7955-5452)
- Haiyan Zhang (ORCID: https://orcid.org/0009-0002-6401-7090)
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Guangdong Provincial Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Medicine
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1097/md.0000000000046924
- Citations
- 1
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 24.43